仅用于工业应用或科学研究，不可用于人类或动物的临床诊断或治疗，非药用. Amatuximab （MORab-009） is a chimeric, humanized IgG1/k MAb that targets the cell surface mesothelin （MSLN）. Mesothelin is a glycosylphosphatidyl inositol （GPI）-anchored membrane glycoprotein, which is present in a restricted set of normal adult tissues such as the mesothelium